What is GSTC stock price today?

GSTC (AngioSoma Inc) stock is trading at $0.00 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is GSTC stock going up or down today?

GSTC stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy GSTC stock now?

The decision to buy GSTC depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is GSTC a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for GSTC based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is GSTC stock overvalued or undervalued?

Use our DCF valuation calculator to determine if GSTC is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is GSTC's P/E ratio?

P/E ratio data for GSTC will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is GSTC's market cap?

GSTC (AngioSoma Inc) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is GSTC's price to book ratio?

Price-to-book ratio for GSTC is available on our dashboard along with other valuation metrics.

Does GSTC pay dividends?

GSTC does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is GSTC's dividend yield?

GSTC does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is GSTC stock a good long-term investment?

GSTC's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is GSTC's revenue growth rate?

Revenue growth data for GSTC is available on our dashboard with detailed financial statement analysis.

Profitability metrics for GSTC are available on our dashboard with complete income statement analysis.

What are the risks of investing in GSTC?

Key risks for GSTC include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does GSTC compare to its competitors?

Compare GSTC to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize GSTC's performance and positioning.

What is GSTC's stock price target for 2026?

Our AI model provides price targets for GSTC based on fundamental analysis: Bull case $0.00 (+30%), Base case $0.00 (+15%), Bear case $0.00 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about GSTC?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for GSTC. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is GSTC's next earnings report?

GSTC reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

GSTC - AngioSoma Inc

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About AngioSoma Inc

GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, engages in the provision of patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases in the United States. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. GlobeStar Therapeutics Corporation is based in New York, New York.

Price Chart

Loading chart...

GSTC Key Statistics

Market Cap

$0.12M

000

How GSTC Compares to Peers

GSTC is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
GSTC(This stock)	$124.11K	N/A	0%	0.0%	-
AMGNAmgen Inc	$186.52B	24.0	0%	0.2%	vs AMGN
GILDGilead Sciences	$160.39B	17.6	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$112.12B	26.2	0%	0.4%	vs VRTX
REGNRegeneron Pharmaceuticals	$66.84B	15.6	0%	0.3%	vs REGN
BIIBBiogen Inc	$29.00B	21.1	0%	0.1%	vs BIIB

AngioSoma Inc Company Information

Headquarters: 1280 Lexington Avenue, New York, NY, United States, 10028, undefined
Website: www.globestartherapeutics.com
Sector: Healthcare
Industry: Biotechnology

Data Updated: June 5, 2026 at 12:56 PM EDT

Ready to invest in GSTC?

Commission-free trading available. Affiliate links.

Upcoming Events for GSTC

Dashboard

Enter a ticker to analyze